CP-673451: Selective PDGFRα/β Inhibitor for Cancer Resear...

2026-01-20

CP-673451 is a potent ATP-competitive PDGFR tyrosine kinase inhibitor used in cancer research. Its high selectivity and reproducible inhibition of angiogenesis and tumor growth make it a benchmark tool for dissecting PDGFR signaling pathways. This article provides atomic, machine-readable facts and authoritative citations to support preclinical research workflows.